ReCAP: Cost Differential of Chemotherapy for Solid Tumors

Abstract

A significant cost differential exists between chemotherapeutic regimens for the most common solid tumors. Incorporation of costs and incremental effectiveness in current guidelines may encourage socially responsible practice patterns.